Φορτώνει......
Point-of-care testing of coagulation in patients treated with edoxaban
Edoxaban, alongside other direct oral anticoagulants (DOAC), is increasingly used for prevention of thromboembolism, including stroke. Despite DOAC therapy, however, annual stroke rate in patients with atrial fibrillation remains 1–2%. Rapid exclusion of relevant anticoagulation is necessary to guid...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Thromb Thrombolysis |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Springer US
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7515947/ https://ncbi.nlm.nih.gov/pubmed/32436010 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11239-020-02143-2 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|